Submission for OMB Review; Comment Request; Healthy Marriage and Responsible Fatherhood Performance Measures and Additional Data Collection (New Collection)
| Published date | 01 March 2021 |
| Citation | 86 FR 12006 |
| Record Number | 2021-04162 |
| Section | Notices |
| Court | Children And Families Administration |
12006
Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices
++ Determine the adequacy of
ACHC’s staff and other resources.
++ Confirm ACHC’s ability to provide
adequate funding for performing
required surveys.
++ Confirm ACHC’s policies with
respect to surveys being unannounced.
++ Confirm ACHC’s policies and
procedures to avoid conflicts of interest,
including the appearance of conflicts of
interest, involving individuals who
conduct surveys or participate in
accreditation decisions.
++ Obtain ACHC’s agreement to
provide CMS with a copy of the most
current accreditation survey together
with any other information related to
the survey as we may require, including
corrective action plans.
In accordance with section
1865(a)(3)(A) of the Act, the September
28, 2020 proposed notice also solicited
public comments regarding whether
ACHC’s requirements met or exceeded
the Medicare CoPs for HHAs. No
comments were received in response to
our proposed notice.
IV. Provisions of the Final Notice
A. Differences Between ACHC’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements
We compared ACHC’s HHA
accreditation requirements and survey
process with the Medicare CoPs of parts
409 and 484, and the survey and
certification process requirements of
parts 488 and 489. Our review and
evaluation of ACHC’s HHA application,
which were conducted as described in
section III. of this final notice, yielded
the following areas where, as of the date
of this notice, ACHC has completed
revising its standards and certification
processes in order to meet the following
requirements:
•Section 484.102(b) to include the
requirement to review and update
emergency preparedness policies and
procedures at least every 2 years.
•Section 484.105(b)(1)(i) to ensure
that the administrator is appointed by
and reports to the governing body.
•Section 488.26(b) to ensure
surveyor documentation relating to non-
compliance with particular Medicare
conditions reflects the manner and
degree of non-compliance, cited at the
appropriate level (that is, condition
versus standard level).
•Section 488.5(a)(4)(vii) to describe
ACHC’s procedures and timelines for
monitoring provider’s or supplier’s
correction of identified non-compliance
with relevant standards, including the
criteria ACHC uses to determine when
a desk review versus an on-site review
would be acceptable for monitoring the
correction of non-compliance.
B. Term of Approval
Based on our review and observations
described in section III. of this final
notice, we approve ACHC as a national
accreditation organization for HHAs that
request participation in the Medicare
program, effective February 24, 2021
through February 24, 2025.
V. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting recordkeeping or third-
party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Acting Administrator of the
Centers for Medicare & Medicaid
Services (CMS), Elizabeth Richter,
having reviewed and approved this
document, authorizes Lynette Wilson,
who is the Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: February 24, 2021.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2021–04169 Filed 2–26–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request; Healthy Marriage
and Responsible Fatherhood
Performance Measures and Additional
Data Collection (New Collection)
AGENCY
: Office of Planning, Research,
and Evaluation, Administration for
Children and Families, HHS.
ACTION
: Request for public comment.
SUMMARY
: The Administration for
Children and Families (ACF), Office of
Family Assistance (OFA) has had
administrative responsibility for federal
funding of programs that strengthen
families through healthy marriage and
relationship education and responsible
fatherhood programming since 2006,
through the Healthy Marriage (HM) and
Responsible Fatherhood (RF) Grant
Programs. ACF required the 2015 cohort
of HMRF grantees—which received 5-
year grants in September 2015—to
collect and report performance
measures about program operations,
services, and clients served (OMB
#0970–0460). A performance measures
data collection system called nFORM
(Information, Family Outcomes,
Reporting, and Management) was
implemented with the 2015 cohort to
improve the efficiency of data collection
and reporting and the quality of data.
This system allows for streamlined and
standardized submission of grantee
performance data through regular
progress reports and supports grantee-
led and federal research projects. ACF
will continue performance measure and
other data collection activities for the
HMRF grant program with a new cohort
of grantees who received 5-year awards
in September 2020. ACF is requesting
comment on a new data collection to
support these activities with the 2020
HMRF grantee cohort. ACF has made
changes to the previous cohort’s data
collection instruments and performance
reports for use in the new cohort. This
new grantee cohort is expected to begin
collecting performance measure data
and reporting to ACF in April 2021.
DATES
: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
ADDRESSES
: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION
:
Description: ACF proposes to collect a
set of performance measures from all
HMRF grantees. These measures collect
standardized information in the
following areas:
•Applicant characteristics;
•Program operations;
•Service delivery; and
•Participant outcomes:
ÆEntrance survey, with five versions:
(1) HM Program Entrance Survey for
Adult-Focused Programs; (2) HM
Program Entrance Survey for Youth-
Focused Programs; (3) RF Program
Entrance Survey for Community-Based
Fathers; (4) RF Program Entrance Survey
for Community-Based Mothers; and (5)
VerDate Sep<11>2014 18:48 Feb 26, 2021 Jkt 253001 PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\01MRN1.SGM 01MRN1
12007
Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices
RF Program Entrance Survey for
Reentering Fathers.
ÆExit survey, with five versions: (1)
HM Program Exit Survey for Adult-
Focused Programs; (2) HM Program Exit
Survey for Youth-Focused Programs; (3)
RF Program Exit Survey for Community-
Based Fathers; (4) RF Program Exit
Survey for Community-Based Mothers;
and (5) RF Program Exit Survey for
Reentering Fathers.
The measures used by the 2015
grantee cohort were developed in 2014
after extensive review of the research
literature and grantees’ past measures.
The performance measures, data
collection instruments, and data
collection system were revised in 2020
based on a targeted analysis of existing
measures, feedback from key
stakeholders, and discussions with ACF
staff and the 2015 cohort of grantees.
ACF required the 2015 cohort of
grantees to submit data on these
standardized measures on a quarterly
basis and proposes the same
requirement for the 2020 cohort. In
addition to the performance measures
mentioned above, ACF proposes to
repeat collection for these data
submissions:
•Semi-annual Performance Progress
Report (PPR), with two versions: (1)
Performance Progress Report for HM
Programs, and (2) Performance Progress
Report for RF Programs; and
•Quarterly Performance Report
(QPR), with two versions: (1) Quarterly
Performance Progress Report for HM
Programs, and (2) Quarterly
Performance Progress Report for RF
Programs.
Grantees in the new cohort will also
be required to engage in continuous
quality improvement (CQI) planning
and implementation using a proposed
CQI plan template developed by ACF.
The estimated burden for completing
and updating this template is included
in the table below.
Respondents: Respondents include
HM and RF grantee staff and program
applicants and participants (participants
are called ‘‘clients’’).
A
NNUAL
B
URDEN
E
STIMATES
Instrument Respondent
Number of
respondents
(total over
request
period)
Number of
responses per
respondent
(total over
request
period)
Average
burden per
response
(in hours)
Total
burden
(in hours)
Annual
burden
(in hours)
1: Applicant Characteristics ................. Program applicants ............................. 273,840 1 0.25 68,460.0 22,820.0
Program staff ...................................... 408 672 0.10 27,417.6 9,139.2
2: Program Operations ........................ Program staff ...................................... 136 12 0.32 522.24 174.08
3: Service Delivery Data ...................... Program staff ...................................... 2,040 126 0.50 128,520.0 42,840.0
4: Entrance and Exit Surveys .............. Program clients (entrance) ................. 257,409 1 0.42 108,111.78 36,037.26
Program clients (exit) .......................... 169,965 1 0.42 71,385.3 23,795.1
Program staff (entrance and exit on
paper). 32 3,506 0.10 11,219.2 3,739.73
5: Semi-annual Performance Progress
Report (PPR). Program staff ...................................... 136 6 3 2,448.0 816.0
6: Quarterly Performance Report
(QPR). Program staff ...................................... 136 6 1 816.0 272.0
7: CQI Plan .......................................... Program staff ...................................... 136 3 4 1,632 544.0
Estimated Total Annual Burden
Hours: 140,177.37.
Authority: Sec. 403. [42 U.S.C. 603].
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2021–04162 Filed 2–26–21; 8:45 am]
BILLING CODE 4184–73–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY
: National Institutes of Health,
HHS.
ACTION
: Notice.
SUMMARY
: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development.
FOR FURTHER INFORMATION CONTACT
:
Licensing information and copies of
patent applications may be obtained by
emailing Brian W. Bailey, Ph.D.,
bbailey@mail.nih.gov, the indicated
licensing contact at the National Heart,
Lung, and Blood, Office of Technology
Transfer and Development Office of
Technology Transfer, 31 Center Drive,
Room 4A29, MSC2479, Bethesda, MD
20892–2479; telephone: 301–402–5579.
A signed Confidential Disclosure
Agreement may be required to receive
any unpublished information.
SUPPLEMENTARY INFORMATION
:
Technology description follows.
Use of Statins To Treat or Prevent Drug-
Induced Hearing Loss
Description of Technology
Available for licensing and
commercial development are patent
rights covering methods of using
atorvastatin and related statin
compounds and derivatives to reduce or
prevent drug-induced hearing loss that
is caused as a side effect by ototoxic
drugs such as cisplatin, which is
commonly used in cancer therapies. At
present, permanent hearing loss occurs
in approximately half of all patients
treated with cisplatin; consequently,
every year many thousands of
individuals experience partial loss of
hearing and associated quality of life
issues as a result of medically necessary
chemoradiation therapies to treat their
cancers. This technology addresses a
large unmet need to eliminate or reduce
hearing loss in patients that must
undergo therapies involving ototoxic
drugs.
This technology is available for
licensing for commercial development
in accordance with 35 U.S.C. 209 and 37
CFR part 404.
Potential Commercial Applications
•Repurposing existing statins,
including atorvastatin, to treat or protect
against permanent hearing loss arising
from chemoradiation therapy involving
ototoxic drugs.
•Development of statin analogues or
derivatives with enhanced abilities to
treat or protect against hearing loss
resulting from therapies involving
cisplatin or other ototoxic drugs.
VerDate Sep<11>2014 18:48 Feb 26, 2021 Jkt 253001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\01MRN1.SGM 01MRN1
